Avenue Therapeutics Incentive Plan Awards Key Executives
Company Announcements

Avenue Therapeutics Incentive Plan Awards Key Executives

An update from Avenue Therapeutics ( (ATXI) ) is now available.

Avenue Therapeutics, Inc. has awarded equity incentives to key executives under its 2015 Incentive Plan. CEO Alexandra MacLean received 170,000 restricted stock units (RSUs), while Interim CFO and COO David Jin was granted 65,000 RSUs. These awards vest over four installments on specified dates from 2024 to 2026, contingent on continued service to the company. The RSUs will be settled either upon the employee’s departure under specific conditions or during a change in company control.

See more insights into ATXI stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyAllarity appoints Alex Epshinsky as CFO
TipRanks Auto-Generated NewsdeskAvenue Therapeutics Stockholders Approve Key Proposals
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App